(Q39638265)

13 September 2017

The expression of the miRNA-200 family in endometrial endometrioid carcinoma (English)

1 reference

13 September 2017

Jeong-Won Lee

1

1 reference

13 September 2017

Young-Ae Park

2

1 reference

13 September 2017

Jung-Joo Choi

3

1 reference

13 September 2017

Yoo Young Lee

4

1 reference

13 September 2017

Chul-Jung Kim

5

1 reference

13 September 2017

ChelHun Choi

6

1 reference

13 September 2017

Tae-Joong Kim

7

1 reference

13 September 2017

Nak Woo Lee

8

1 reference

13 September 2017

Byoung-Gie Kim

9

1 reference

13 September 2017

Duk-Soo Bae

10

1 reference

13 September 2017

language of work or name

English

0 references

publication date

28 October 2010

1 reference

13 September 2017

1 reference

13 September 2017

120

1 reference

13 September 2017

1

1 reference

13 September 2017

56-62

1 reference

13 September 2017

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.022

Management of advanced-stage and recurrent endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.022

Epirubicin in advanced endometrial adenocarcinoma: a phase II study of the grupo ginecologico Español para el tratamiento oncologico (GGETO)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.022

A phase II study of Cis-platinum for recurrent corpus cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.022

Treatment options for advanced endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.022

The promise of microRNA replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.022

The microRNA pathway and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.022

Targeting miRNAs for drug discovery: a new paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.022

MicroRNAs--targeting and target prediction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.022

Targeting of mRNAs by multiple miRNAs: the next step

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.022

Expression profile of mammalian microRNAs in endometrioid adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.022

Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.022

MicroRNAs and their target messenger RNAs associated with endometrial carcinogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.022

Altered MicroRNA expression in cervical carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.022

Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.022

MicroRNA signatures differentiate uterine cancer tumor subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.022

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.022

The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.022

The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.022

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.022

MicroRNAs as regulators of epithelial-mesenchymal transition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.022

Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.022

MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.022

MicroRNA signatures in human ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.022

MicroRNA expression profiles in serous ovarian carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.022

Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.022

Histopathology of endometrial hyperplasia and endometrial carcinoma: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.022

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.09.022

10.1016/J.YGYNO.2010.09.022

7 January 2021

Identifiers

DOI

1 reference

13 September 2017

1 reference